Skip to Content
Søg Menu

EHA 2024 I The European Hematology Association

Dansk Aften EHA 2025 – Milano

Du har nu mulighed for at tilmelde dig til Dansk Aften EHA 2025 i Milano. Mød dine kolleger og få en opsummering af nyheder og highlights fra kongressen – efterfulgt af netværk og middag.

EHA 2024

Several Trials Showed Improvements in the Treatment of Multiple Myeloma

  • / BestPractice Nordic

Anne Stidsholt Roug

Opdateringer fra EHA: Nye behandlingsmuligheder for AML og APL

/ Anne Stidsholt Roug
EHA24 Play the Video

Hematology • Meet the Experts

Get access

EHA 2024: One of the Most Important for Many Years

/ BestPractice Nordic
EHA24Lymfom

CLL: Needs At Least 10 Years of Follow-Up for Clinical Trials

/ BestPractice Nordic
EHA24CLL

The Development of New Treatment Options within AML Is Slower Than in Other Disease Areas within Hematology

/ BestPractice Nordic
EHA24AML

New Data from EHA Shared and Discussed at Danish Evening

/ Jan Andreasen
EHA24
Tarec Christoffer El-galaly

Opsigtvækkende fremskridt på EHA for behandling af lymfom

/ Tarec Christoffer El-Galaly
EHA24Lymfom Play the Video
Maria Eugenia Chollet

Promising Avenues for the Development of Personalized Treatment for FVII Deficiency

/ Maria Eugenia Chollet
EHA24 Play the Video
Hent flere

Mest sete

MEDtalks

Vaccinating Against Mutated RAS in Multiple Myeloma

/ Hæmatologi / Hanne Norseth

An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies

/ Hæmatologi / Sergio Martinez Høyer

Treating MRD Relapse After First-Line Treatment May Prolong PFS and OS in Myeloma Patients

/ Hæmatologi / Frida Bugge Askeland

Artikler

EHA24: LBA – Potential Frontline Treatment for Elderly Patients with Untreated Mantle Cell Lymphoma

/ Hæmatologi / Isabella Rosa Staffe

EHA24: New Treatment Regimen Marks a Breakthrough for Patients with Multiple Myeloma

/ Hæmatologi / Isabella Rosa Staffe

EHA24: Professor John Gribben Awarded Prestigious EHA José Carreras Award 

/ Hæmatologi / Isabella Rosa Staffe
Sigrid S. Skånland

From Genomic Precision Medicine to Functional Precision Medicine in Hematology

/ Sigrid S. Skånland
EHA24 Play the Video
Henrik Hjorth-Hansen

Management of CML in Adults: 2024 ELN Recommendations

/ Henrik Hjorth-Hansen
EHA24 Play the Video
Rasmus Rask Kragh Jørgensen

Development of Prediction Models for Survival among Hodgkin Lymphoma Patients

/ Rasmus Rask Kragh Jørgensen
EHA24Hodgkins lymfom Play the Video
Ângela Mesquita

Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes

/ Ângela Sofia Gerós Mesquita
EHA24 Play the Video
Jelena Jelicic

More Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Can Participate in Clinical Studies

/ Jelena Jelicic
EHA24Lymfom Play the Video
Elin Forsgren

Ibrutinib, Lenalidomide, and Rituximab in Relapsed Mantle Cell Lymphoma

/ Elin Forsgren
EHA24Myelomatose Play the Video
Ari Melnick

Presidential Symposium: Unmet Needs in the Lymphoma Field

/ Ari M. Melnick
EHA24Lymfom Play the Video
Bruno Paiva

Presidential Symposium: Innovative Tools for Disease Monitoring in Multiple Myeloma

/ Bruno Paiva
EHA24Myelomatose Play the Video
Sigrun Thorsteinsdottir

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sigrun Thorsteinsdottir
EHA24Myelomatose Play the Video
Agoston Gyula Szabo

Dansk, investigator-initieret studie af lavdosis VEN-DEX hos patienter med RRMM og t(11;14) opnår en ORR på 50%

/ Agoston Gyula Szabo
EHA24Myelomatose Play the Video
Paolo Ghia

Promising Efficacy of Zanubrutinib + Venetoclax Treatment in Patients with High-Risk Treatment-Naïve CLL/SLL with Del 17p and/or TP53 Mutation

/ Paolo Ghia
EHA24CLL Play the Video
Alessandra Tedeschi

Impact of First-Year Dose Modifications of Acalabrutinib in Patients with CLL

/ Alessandra Tedeschi
EHA24CLL Play the Video
Hent flere

EHA 2023

Carsten Niemann

Overlevelsesgevinst for skrøbelige CLL-patienter i behandling med Imbruvica og Venclyxto

/ Carsten Utoft Niemann
EHA23CLL Play the Video

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sofie Pohl
Myelomatose

EHA24: Danish LBA Shows that Oral Vitamin C Might Improve OS for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions

/ Sofie Pohl
EHA24
Anna Sureda Balari

Epcoritamab with Rituximab and Lenalidomide (R2) for Patients with High-Risk Follicular Lymphoma

/ Anna Sureda Balari
EHA23Lymfom Play the Video
Mark Levis

Gilteritinib for Patients with Newly Diagnosed AML

/ Mark Levis
EHA23Ernæring Play the Video
Arnon Kater

MURANO Study Supports the Use of Fixed-Duration VenR in R/R CLL

/ Arnon Kater
EHA23CLL Play the Video
Evangelos Terpos

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Evangelos Terpos
EHA23Myelomatose Play the Video
Ryan Jacobs

News from EHA23 – A Promising Treatment Option for Follicular Lymphoma

/ Ryan Jacobs
EHA23Lymfom Play the Video
Barbara Eichhorst

What is New from EHA23 Regarding Treatment Strategies in First-Line CLL?

/ Barbara Eichhorst
EHA23CLL Play the Video
Eva Futtrup Maksten

Risk of Dementia in Older Patients Treated with Chemotherapy for Lymphoma

/ Eva Futtrup Maksten
EHA23LymfomDemens Play the Video

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Evangelos Terpos / Jan Andreasen
EHA23Myelomatose
Alan Z. Skarbnik

New Research from EHA23 Points to Similar Effectiveness of Acalabrutinib and Zanubrutinib in R/R CLL Treatment

/ Alan Z. Skarbnik
EHA23CLL Play the Video
Hent flere

Højdepunkter fra EHA webinar 2022

Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
B-celle lymfomLymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video

MEDtalks fra EHA 2022

AML

Functional Characterization for Germline Variants in Patients with MDS and AML

/ Hæmatologi / Nikolaj Juul Nitschke

FLT3 Inhibitor Gilteritinib Shows Potential in Post-Transplant Maintenance for AML

/ Hæmatologi / Mark Levis

Tillæg af andengenerations-FLT3-inhibitor til intensiv kemoterapi og konsolidering hos voksne med AML

/ Hæmatologi / Daniel Kristensen

Nyt landsdækkende studie stiller spørgsmålstegn ved betydningen af dosisreduktion hos overvægtige AML-patienter

/ Hæmatologi / Daniel Kristensen

What Is the Best Treatment for Elderly Patients With AML?

/ Hæmatologi / Bjørn Tore Gjertsen
Se oversigt

CLL

UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies

/ Hæmatologi / Dima El-Sharkawi

MURANO 7-års data viser fortsat effekt ved R/R CLL – men giver ikke svar på alle spørgsmål

/ Hæmatologi / Carsten Utoft Niemann

Dansk/amerikansk studie viser øget dødelighed for patienter med CLL og type 2-diabetes

/ Hæmatologi / Emelie Hamotal Curovic Rotbain

New CLL Study Supports Inclusion of Venetoclax Plus Obinutuzumab in Treatment Guidelines

/ Hæmatologi / Othman Al-Sawaf

CLL14-studiet er tæt på overlevelsesgevinst for skrøbelige patienter med CLL

/ Hæmatologi / Carsten Utoft Niemann
Se oversigt

Lymfom

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

/ Hæmatologi / Ingrid Glimelius

LBA: Acalabrutinib plus Bendamustine and Rituximab Show Significant Improvement in PFS for Elderly Patients with Mantle Cell Lymphoma

/ Hæmatologi / Michael Wang

The Blood Proteome Predicts High Risk of Relapse in Mantle Cell Lymphoma Patients

/ Hæmatologi / Patrick Nylund

EHA24: Updated Results on the AZD-0486 Trial for Treating Relapsed Refractory Follicular Lymphoma

/ Hæmatologi / Ryan Jacobs

Promising Findings for R/R Large B-Cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Hæmatologi / Martin Hutchings
Se oversigt

Myelomatose

New Insights into MM Heterogeneity Among Different Age Groups

/ Hæmatologi / Sigrun Thorsteinsdottir

Multiple Myeloma: Belantamab Mafodotin plus Pomalidomide and Dexamethasone Show Significant Higher PFS, Deep Response and OS vs Those of Standard of Care

/ Hæmatologi / Meletios A. Dimopoulos

Mechanisms of Sensitivity and Resistance of Multiple Myeloma to NK Cells Can Potentially Lead to New Treatments

/ Hæmatologi / Sara Gandolfi

EHA24: How I Treat Relapsed/Refractory Multiple Myeloma in Early Lines

/ Hæmatologi / Fredrik Schjesvold

CRTH Award Winning Study Demonstrates Malignancy Risks for CLL Patients

/ Hæmatologi / Thomas Chatzikonstantinou
Se oversigt

Abstracts fra EHA 2022

Ibrutinib keeps on delivering now as first-line treatment for older patients with mantle cell lymphoma

/ Hæmatologi / BestPractice Nordic

Superior safety profile for decitabine vs chemotherapy for older patient with AML

/ Hæmatologi / BestPractice Nordic

A novel CAR-T cell therapy thas proven highly effective for patients with RRMM

/ Hæmatologi / BestPractice Nordic

A new phase 3 trial shows significantly prolonged overall survival for patients with AML

/ Hæmatologi / BestPractice Nordic

Improved PFS is achievable using targeted therapy combinations with venetoclax in fit patients with treatment naïve CLL 

/ Hæmatologi / BestPractice Nordic

Treatment of Burkitt lymphoma with DA-EPOCH-R is associated with significant less infectious complications, transfusions, and hospitalization days 

  • / BestPractice Nordic

Se highlights EHA webinar 2022

Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
B-celle lymfomLymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video

Gå ikke glip af det nyeste fra Hæmatologi

Skriv dig på og få nye artikler, MEDtalks og magasiner i din indbakke

Send mig seneste nyt fra hæmatologi

Mere fra EHA 2022

Agoston Gyula Szabo

Værdien af højdosisbehandling som tillæg til Rvd induktion og konsolidering ved myelomatose

/ Agoston Gyula Szabo
EHA22Myelomatose Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video
Paolo Strati

Phase 1 Results in SIRPα Antibody CC-95251 in Combination with Rituximab in Patients with R/R NHL

/ Paolo Strati
EHA22Lymfom Play the Video

Mere fra EHA 2021

Significant improvements in OS and RFS for older patients with AML

/ Farhad Ravandi
EHA21AML Play the Video

Iberdomide show promising efficacy in heavily pretreated patients with Relapsed/Refractory Multiple Myeloma

/ Sagar Lonial
EHA21Myelomatose Play the Video

EHA-ESMO Clinical Practice Guidelines for Multiple Myeloma

/ Fredrik Schjesvold
EHA21Myelomatose Play the Video

Potential to become the best treatment for multiple myeloma in history

/ Thierry Facon
EHA21Myelomatose Play the Video

New bispecific antibody with promising efficacy and safety profil for patients with relapsed/refractory Multiple Myeloma

/ Amrita Y. Krishnan
EHA21Myelomatose Play the Video

Azacitidin tolereredes generelt godt af ældre patienter med AML

/ BestPractice Nordic
AlderdomEHA21AML
Læs mere

First-in-human study of teclistamab for relapsed/refractory Multiple Myeloma

/ Niels van de Donk
EHA21Myelomatose Play the Video

Early responses for BCMA-directed CAR-T cell therapy in progressive MM after 1-3 prior lines of therapy

/ Mounzer Agha
EHA21Myelomatose Play the Video

CAR-T-celleterapi giver tidligt og dyb respons ved myelomatose

/ BestPractice Nordic
CAR-TEHA21MyelomatoseT-celler
Back to top